Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marvel Biosciences Corp. AGM Information 2022

Dec 22, 2022

47732_rns_2022-12-22_b2c128c4-7a21-4d85-9077-a558768778f4.pdf

AGM Information

Open in viewer

Opens in your device viewer

December 22, 2022

Filed via SEDAR

To All Applicable Exchanges and Securities Administrators

Subject: Marvel Biosciences Corp. (the "Issuer") Notice of Meeting and Record Date

Dear Sir/Madam:

We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:

Meeting Type: Annual General and Special Meeting
Meeting Date: February 28, 2023
Record Date for Notice of Meeting: January 20, 2023
Record Date for Voting (if applicable): January 20, 2023
Beneficial Ownership Determination Date: January 20, 2023
Class of Securities Entitled to Vote: Common
ISIN: CA57384M1077
Issuer sending proxy materials directly to NOBOs: No
Issuer paying for delivery to OBOs: No
Notice and Access for Beneficial Holders: No
Notice and Access for Registered Holders: No

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

Yours truly,

Odyssey Trust Company as agent for Marvel Biosciences Corp.